Provided by Tiger Trade Technology Pte. Ltd.

Organon & Co

5.84
-0.2100-3.47%
Post-market: 5.900.0600+1.03%19:44 EDT
Volume:2.93M
Turnover:17.34M
Market Cap:1.52B
PE:8.11
High:6.15
Open:6.10
Low:5.83
Close:6.05
52wk High:14.94
52wk Low:5.76
Shares:259.98M
Float Shares:258.73M
Volume Ratio:0.65
T/O Rate:1.13%
Dividend:0.08
Dividend Rate:1.37%
EPS(TTM):0.7200
EPS(LYR):0.7200
ROE:30.56%
ROA:6.22%
PB:2.02
PE(LYR):8.11

Loading ...

BUZZ-Organon rises as review finds no issues in past biosimilar purchases

Reuters
·
Feb 20

Organon & Co: Independent Review Did Not Find Evidence of Improper Conduct Related to Timing of Purchases of Biosimilars From Supplier in Prior Years

THOMSON REUTERS
·
Feb 20

Organon Audit Committee Clears Biosimilar Purchase Timing Review

Reuters
·
Feb 20

Morgan Stanley Keeps Their Hold Rating on Organon (OGN)

TIPRANKS
·
Feb 17

Analysts Have Conflicting Sentiments on These Healthcare Companies: Organon (OGN), Maravai Lifesciences Holdings (MRVI) and Vertex Pharmaceuticals (VRTX)

TIPRANKS
·
Feb 13

BUZZ-U.S. STOCKS ON THE MOVE-FedEx Corp, Lincoln National

Reuters
·
Feb 13

Organon Shares Fall After 4Q Earnings Miss Expectations

Dow Jones
·
Feb 12

Organon Shares Fall 13% After Q4 Profit Miss

THOMSON REUTERS
·
Feb 12

BUZZ-U.S. STOCKS ON THE MOVE-PPG Industries, American Electric Power, West Pharmaceutical

Reuters
·
Feb 12

BUZZ-Organon shares fall after Q4 profit miss

Reuters
·
Feb 12

Organon Q4 sales, profit miss estimates on women's health, respiratory products decline

Reuters
·
Feb 12

GUIDANCE: (OGN) Organon Expects 2026 Revenue About $6.22B, vs. FactSet Est of $6.11B

MT Newswires Live
·
Feb 12

Earnings Flash (OGN) Organon Posts Q4 Adjusted EPS $0.63, vs. FactSet Est of $0.73

MT Newswires Live
·
Feb 12

Stock Track | Organon & Co Plunges 8.84% in Pre-Market After Q4 Earnings Miss Estimates

Stock Track
·
Feb 12

Organon & Co. FY 2025 net income at USD 0.19 billion, down 80%

Reuters
·
Feb 12

BRIEF-Organon Q4 Adjusted EPS USD 0.63 Vs. IBES Estimate USD 0.73

Reuters
·
Feb 12

Organon Q4 Adjusted Ebitda Margin 25.4%

THOMSON REUTERS
·
Feb 12

Organon Q4 Adjusted EPS USD 0.63 VS. Ibes Estimate USD 0.73

THOMSON REUTERS
·
Feb 12

Earning Preview: Organon & Co Q4 revenue is expected to decrease by 3.45%, and institutional views are cautious

Earnings Agent
·
Feb 05

Press Release: Organon To Report Fourth Quarter and Full Year 2025 Results and Host Conference Call on February 12, 2026

Dow Jones
·
Jan 29